Progress Towards Blocking Alternative Lengthening of Telomeres in Cancer

Well, this is promising news. Researchers have found that inhibition of FANCM activity is a potential point of intervention to shut down alternative lengthening of telomeres (ALT) in cancer. This goal is one half of the ultimate cancer therapy, a form of treatment that is (a) capable of shutting down all forms of cancer, without exception, where (b) cancers cannot evolve resistance to its mechanisms, and © it requires little to no expensive, time-consuming adaptation for delivery to different cancer types. The other half is a method of blocking the ability of telomerase to lengthen telomeres, and several research groups have made inroads towards that goal. Both are needed in combination, since ALT cancers might evolve to become telomerase cancers, and vice versa. Why would this

from https://www.fightaging.org/archives/2019/06/progress-towards-blocking-alternative-lengthening-of-telomeres-in-cancer/

from
https://healthnews010.tumblr.com/post/185400285673

From https://johnher1.blogspot.com/2019/06/progress-towards-blocking-alternative.html

from
https://johnher1.wordpress.com/2019/06/06/progress-towards-blocking-alternative-lengthening-of-telomeres-in-cancer/